saxenda glp-1 diabetes market impact Obesity drugs could fuel the next pharma CMO gold rush GLP-1 Receptor Agonist Market Size

It is in the pipeline for receiving GRAS certification

Just because its cheaper doesnt mean its better or safe

Further, many employers (as high as 59% of employers with at least 5,000 workers) that offered such coverage said that use of GLP-1 medications was higher than expected, and 66% of the largest employers said that covering such drugs for weight loss had a significant impact on their health plans prescription drug spending

Your healthcare provider will help determine which medication is best suited for you, based on factors such as: Both medications can be used effectively with a balanced diet, regular exercise, and ongoing support